SightfileU.S. market data from official filings

MOONLAKE IMMUNOTHERAPEUTICS (MLTX)

Name: MOONLAKE IMMUNOTHERAPEUTICS (MLTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001821586 · EDGAR filings · Updated 2026-07-23

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) has reported institutional ownership of 85.6%, with 146 institutional managers holding positions valued at $1.17B per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

85.6%

Institutional managers

146

Reported 13F value

$1.17B

Insider activity

21 trans.

−$53.9M net selling

Data flags

2 active

from SEC filings

Filings this week (1)

2026-07-23 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-21 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-15 — Notice of proposed sale filed (Form 144)
2026-07-15 — Current report (8-K) filed
2026-07-13 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MOONLAKE IMMUNOTHERAPEUTICS has 146 institutional holders and institutional ownership of 85.6%.

Insider activity

Insiders reported 21 transactions (1 buys, 10 sells) across 6 reporting insiders, with a net reported value of −$53.9M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-02-25 (recurring since 2021-11-12) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-12-03 (recurring since 2021-12-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BIOHAVEN LTD F (BHVN) · CONMED CORP COM (CNMD) · ORGANON & CO (OGN) · SAVARA INC (SVRA) · GENERATE BIOMEDICINES INC (GENB) · EYEPOINT INC COM NEW (EYPT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.